concept

COMPLEMENT ACTIVATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about COMPLEMENT ACTIVATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

72Connections

2Hypotheses

3Analyses

47Outgoing

25Incoming

0Experiments

3Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	COMPLEMENT ACTIVATION
Key Genes/Proteins	ALPHA-SYNUCLEIN, AMYLOID, COMPLEMENT, INFLAMMASOME
Related Diseases	ALZHEIMER'S DISEASE, INFLAMMATION
Related Pathways	COMPLEMENT CASCADE

Pathway Diagram

graph TD
    COMPLEMENT_ACTIVATION["COMPLEMENT ACTIVATION"]
    COMPLEMENT_ACTIVATION -->|"causes"| Retinal_Ganglion_Cell_Dysfunct["Retinal Ganglion Cell Dysfunction"]
    COMPLEMENT_ACTIVATION -->|"causes"| Brain_Inflammation["Brain Inflammation"]
    COMPLEMENT_ACTIVATION -->|"activates"| MICROGLIA["MICROGLIA"]
    COMPLEMENT_ACTIVATION -->|"promotes"| Neurodegeneration["Neurodegeneration"]
    COMPLEMENT_ACTIVATION -->|"mediates"| Tissue_Destruction["Tissue Destruction"]
    COMPLEMENT_ACTIVATION -->|"contributes to"| Alzheimer_s_Disease["Alzheimer's Disease"]
    NPTX2["NPTX2"] -->|"inhibits"| COMPLEMENT_ACTIVATION
    Microglia["Microglia"] -->|"upregulates"| COMPLEMENT_ACTIVATION
    C1Q["C1Q"] -->|"activates"| COMPLEMENT_ACTIVATION
    C1QA["C1QA"] -->|"regulates"| COMPLEMENT_ACTIVATION
    Progranulin["Progranulin"] -->|"regulates"| COMPLEMENT_ACTIVATION
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| COMPLEMENT_ACTIVATION
    ASTROCYTES["ASTROCYTES"] -->|"activates"| COMPLEMENT_ACTIVATION
    COMPLEMENT["COMPLEMENT"] -->|"activates"| COMPLEMENT_ACTIVATION

Outgoing (47)

Target	Relation	Type	Str
MICROGLIA	activates	cell_type	0.95
Retinal Ganglion Cell Dysfunction	causes	phenotype	0.95
Neurodegeneration	promotes	process	0.95
Brain Inflammation	causes	process	0.95
Brain Inflammation	promotes	process	0.95
Alzheimer's Disease	contributes_to	disease	0.90
Neuromyelitis Optica Spectrum Disorder	drives	disease	0.90
Retinal Ganglion Cell Death	causes	phenotype	0.90
Alzheimer's disease	involved_in	disease	0.90
Tissue Destruction	mediates	mechanism	0.90
Tissue Destruction	causes	process	0.90
Schizophrenia	contributes_to	disease	0.85
SYNAPTIC LOSS	contributes_to	entity	0.85
Neuroinflammation	associated_with	process	0.85
Synaptic Loss	contributes_to	phenotype	0.80
neurodegeneration	causes	process	0.80
Alzheimer's disease	drives	disease	0.80
Vascular Dysfunction	contributes_to	phenotype	0.80
ALZHEIMER'S DISEASE	biomarker_for	disease	0.80
synapse elimination	causes (excessive complement activation leads to neurotoxi)	mechanism	0.75
Cerebral Amyloid Angiopathy	contributes_to	disease	0.75
Cerebral Amyloid Angiopathy	involved_in	disease	0.75
SYNAPTIC LOSS	causes	phenotype	0.70
AMYLOID	causes	protein	0.70
NEURONS	exacerbates	cell_type	0.70
neuroinflammation	drives	mechanism	0.70
synaptic pruning	activates	process	0.70
synapse loss	causes	process	0.70
INFLAMMATION	causes	phenotype	0.65
INFLAMMATION	implicated_in	phenotype	0.55
CORTEX	associated_with	brain_region	0.50
COMPLEMENT CASCADE	associated_with	pathway	0.50
AMYLOID PET	associated_with	biomarker	0.50
PHAGOCYTOSIS	activates	process	0.50
RETINA	associated_with	brain_region	0.45
NLRP3 INFLAMMASOME	associated_with	pathway	0.45
HIPPOCAMPUS	associated_with	brain_region	0.45
CHOROID PLEXUS	associated_with	brain_region	0.45
INFLAMMATION	activates	process	0.35
NEURODEGENERATION	activates	process	0.35
NEURON	activates	cell_type	0.35
TREM2	activates	gene	0.35
CORTEX	activates	brain_region	0.35
NEUROINFLAMMATION	activates	process	0.35
MACROPHAGES	activates	cell_type	0.35
OXIDATIVE STRESS	activates	process	0.35
INFLAMMASOME	activates	protein	0.35

Incoming (25)

Source	Relation	Type	Str
NPTX2	inhibits	protein	0.95
MICROGLIA APOE LIPOPROTEINS	involved_in	protein	0.85
TREM2	upregulates	gene	0.85
Microglia	upregulates	cell_type	0.85
Microglia	associated_with	cell_type	0.85
SPI1	associated_with	gene	0.80
Amyloid Plaques	associated_with	biomarker	0.80
MICROGLIA	inhibits	cell_type	0.70
C5AR1	mediates	gene	0.70
C1Q	activates	protein	0.70
C1QA	regulates	gene	0.70
APOE	modulates	gene	0.70
MICROGLIA	interacts_with	cell_type	0.65
INFLAMMATION	targets	phenotype	0.65
TREM2	inhibits	gene	0.65
TREM2	interacts_with	gene	0.65
TREM2	regulates	gene	0.65
SPI1	interacts_with	gene	0.65
MICROGLIA	degrades	cell_type	0.65
Progranulin	regulates	protein	0.60
ALZHEIMER'S DISEASE	activates	disease	0.50
ASTROCYTES	activates	cell_type	0.50
COMPLEMENT	activates	protein	0.50
ANGIOGENESIS	activates	process	0.35
ALPHA-SYNUCLEIN	activates	gene	0.35

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
SUMO1-Mediated Synaptotagmin-1 SUMOylation at Lys124 Impairs	0.652	neurodegeneration	What are the specific PTM changes in syn
Direct C1q Binding Enables FcγR-Independent Complement Activ	0.138	molecular biology	Does Alectinib truly bind C1q directly w